Maternal Screen (Quad test) 1st Trimester with Preeclampsia Test
50+ booked in last 3 daysOverview
Preeclampsia is a pregnancy complication characterized by high blood pressure and signs of damage to another organ system, most often the liver and kidneys.
Summary Price Of Maternal Screen (Quad test) 1st Trimester with Preeclampsia Test
We are a trusted lab, offering Maternal Screen (Quad test) 1st Trimester with Preeclampsia Test with a transparent pricing structure.
The cost of Maternal Screen (Quad test) 1st Trimester with Preeclampsia Test in India varies as per the city in India.
The average price of Maternal Screen (Quad test) 1st Trimester with Preeclampsia Test ranges from ₹200 to ₹4900.
The price for the test in the following cities is:
- Chennai: ₹4,900
- Delhi: ₹4,900
- Mumbai: ₹4,900
- Pune: ₹4,900
Contact Metropolis to book an appointment online.
Frequently Asked Questions
This test screens for Down Syndrome, Patau Syndrome and Edward Syndrome in the developing fetus using maternal blood as the sample.
This test is for pregnant females in their 11-13 weeks of pregnancy.
Preeclampsia is a pregnancy complication characterized by high blood pressure and signs of damage to another organ system, most often the liver and kidneys. Preeclampsia usually begins after 20 weeks of pregnancy in women whose blood pressure had been normal. Test includes Free beta HCG, PAPPa, AFP and PLGF. (NT can be added for better detection rate) Recommended at (gestational age) : 11 to 13.6 This test screens for Down Syndrome, Patau Syndrome and Edward Syndrome in the developing fetus using maternal blood as the sample.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.